Medicinal and recreational uses of Cannabis sativa, commonly known as cannabis or hemp,
has increased following its legalization in certain regions of the world. Cannabis and hemp …

The management of visceral pain in patients with disorders of gut–brain interaction, notably
irritable bowel syndrome, presents a considerable clinical challenge, with few available …

Background Compared to plant/flower cannabis products, cannabis concentrates have
higher average potency of delta-9-tetrahydrocannabinol (Δ9-THC), which may be …

Background Highly-potent cannabis products, eg, concentrates, entail greater risks of
cannabis-related harms than lower-potency products such as plant or flower material …

Background: Medicinal cannabis prescriptions are on the rise in Australia, and general
practitioners will increasingly encounter patients using cannabis-based products. Objective …

Importance Cannabis hyperemesis syndrome is an emerging clinical issue associated with
cannabis use. Legalization of cannabis has led to an increase in vomiting-related illnesses …

Introduction Cannabinoid hyperemesis syndrome (CHS) is an uncommon but unique
disorder defined by recurrent abdominal pain, intractable nausea, and emesis in patients …

Introduction: Several forms of cannabinoids are currently being used to manage nausea and
vomiting (N/V). Emerging cases of refractory N/V associated with chronic cannabis use …

PURPOSE To guide clinicians, adults with cancer, caregivers, researchers, and oncology
institutions on the medical use of cannabis and cannabinoids, including synthetic …

Background Adults with cannabis hyperemesis syndrome (CHS) are increasingly presenting
to the emergency department (ED), and this systematic review will evaluate the direct …